The invention discloses compounds of Formula (I). The compounds of formula (I) are TRPA1 antagonists and are useful as active ingredients of pharmaceutical compositions for the treatment of pain and other conditions ameliorated by the inhibition of TRPA1 receptors.
本发明公开了式(I)化合物。式(I)化合物是TRPA1
拮抗剂,可作为药物组合物的活性成分,用于治疗疼痛和其他通过抑制TRPA1受体而缓解的病症。